Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4229451438', 'doi': 'https://doi.org/10.3389/fonc.2022.888810', 'title': 'OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells', 'display_name': 'OGG1 Inhibition Triggers Synthetic Lethality and Enhances The Effect of PARP Inhibitor Olaparib in BRCA1-Deficient TNBC Cells', 'publication_year': 2022, 'publication_date': '2022-05-10', 'ids': {'openalex': 'https://openalex.org/W4229451438', 'doi': 'https://doi.org/10.3389/fonc.2022.888810', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/35619904'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.3389/fonc.2022.888810', 'pdf_url': 'https://www.frontiersin.org/articles/10.3389/fonc.2022.888810/pdf', 'source': {'id': 'https://openalex.org/S2596394214', 'display_name': 'Frontiers in Oncology', 'issn_l': '2234-943X', 'issn': ['2234-943X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320527', 'host_organization_name': 'Frontiers Media', 'host_organization_lineage': ['https://openalex.org/P4310320527'], 'host_organization_lineage_names': ['Frontiers Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.frontiersin.org/articles/10.3389/fonc.2022.888810/pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5010360250', 'display_name': 'Juan Miguel Baquero', 'orcid': 'https://orcid.org/0000-0002-6488-7742'}, 'institutions': [{'id': 'https://openalex.org/I4210089594', 'display_name': 'Spanish National Cancer Research Centre', 'ror': 'https://ror.org/00bvhmc43', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210089594']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Juan Miguel Baquero', 'raw_affiliation_strings': ['Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019654113', 'display_name': 'Erik Michel Marchena-Perea', 'orcid': 'https://orcid.org/0000-0002-3650-0387'}, 'institutions': [{'id': 'https://openalex.org/I4210089594', 'display_name': 'Spanish National Cancer Research Centre', 'ror': 'https://ror.org/00bvhmc43', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210089594']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Erik Marchena-Perea', 'raw_affiliation_strings': ['Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040464281', 'display_name': 'Rocío Mirabet', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210089594', 'display_name': 'Spanish National Cancer Research Centre', 'ror': 'https://ror.org/00bvhmc43', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210089594']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Rocío Mirabet', 'raw_affiliation_strings': ['Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053728594', 'display_name': 'Raúl Torres', 'orcid': 'https://orcid.org/0000-0001-9606-0398'}, 'institutions': [{'id': 'https://openalex.org/I4210089594', 'display_name': 'Spanish National Cancer Research Centre', 'ror': 'https://ror.org/00bvhmc43', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210089594']}, {'id': 'https://openalex.org/I4210165411', 'display_name': 'Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas', 'ror': 'https://ror.org/05xx77y52', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210165411']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Raúl Torres-Ruiz', 'raw_affiliation_strings': ['Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain', 'Molecular Cytogenetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Molecular Cytogenetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}, {'raw_affiliation_string': 'Division of Hematopoietic Innovative Therapies, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210165411']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029217625', 'display_name': 'Carmen Blanco‐Aparicio', 'orcid': 'https://orcid.org/0000-0002-3249-6595'}, 'institutions': [{'id': 'https://openalex.org/I4210089594', 'display_name': 'Spanish National Cancer Research Centre', 'ror': 'https://ror.org/00bvhmc43', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210089594']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Carmen Blanco-Aparicio', 'raw_affiliation_strings': ['Experimental Therapeutics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Experimental Therapeutics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070546535', 'display_name': 'Sandra Rodríguez', 'orcid': 'https://orcid.org/0000-0001-7221-3636'}, 'institutions': [{'id': 'https://openalex.org/I4210089594', 'display_name': 'Spanish National Cancer Research Centre', 'ror': 'https://ror.org/00bvhmc43', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210089594']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Sandra Rodríguez-Perales', 'raw_affiliation_strings': ['Molecular Cytogenetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Molecular Cytogenetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029296072', 'display_name': 'Thomas Helleday', 'orcid': 'https://orcid.org/0000-0002-7384-092X'}, 'institutions': [{'id': 'https://openalex.org/I91136226', 'display_name': 'University of Sheffield', 'ror': 'https://ror.org/05krs5044', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I91136226']}, {'id': 'https://openalex.org/I2800139495', 'display_name': 'Science for Life Laboratory', 'ror': 'https://ror.org/04ev03g22', 'country_code': 'SE', 'type': 'facility', 'lineage': ['https://openalex.org/I2800139495']}, {'id': 'https://openalex.org/I28166907', 'display_name': 'Karolinska Institutet', 'ror': 'https://ror.org/056d84691', 'country_code': 'SE', 'type': 'education', 'lineage': ['https://openalex.org/I28166907']}], 'countries': ['GB', 'SE'], 'is_corresponding': False, 'raw_author_name': 'Thomas Helleday', 'raw_affiliation_strings': ['Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden', 'Sheffield Cancer Centre, Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'Sheffield Cancer Centre, Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom', 'institution_ids': ['https://openalex.org/I91136226']}, {'raw_affiliation_string': 'Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden', 'institution_ids': ['https://openalex.org/I2800139495', 'https://openalex.org/I28166907']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074467963', 'display_name': 'Carlos Benítez‐Buelga', 'orcid': 'https://orcid.org/0009-0006-3097-1109'}, 'institutions': [{'id': 'https://openalex.org/I2800139495', 'display_name': 'Science for Life Laboratory', 'ror': 'https://ror.org/04ev03g22', 'country_code': 'SE', 'type': 'facility', 'lineage': ['https://openalex.org/I2800139495']}, {'id': 'https://openalex.org/I28166907', 'display_name': 'Karolinska Institutet', 'ror': 'https://ror.org/056d84691', 'country_code': 'SE', 'type': 'education', 'lineage': ['https://openalex.org/I28166907']}], 'countries': ['SE'], 'is_corresponding': False, 'raw_author_name': 'Carlos Benítez-Buelga', 'raw_affiliation_strings': ['Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden'], 'affiliations': [{'raw_affiliation_string': 'Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden', 'institution_ids': ['https://openalex.org/I2800139495', 'https://openalex.org/I28166907']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052211470', 'display_name': 'Javier Benı́tez', 'orcid': 'https://orcid.org/0000-0002-0923-7202'}, 'institutions': [{'id': 'https://openalex.org/I4210089594', 'display_name': 'Spanish National Cancer Research Centre', 'ror': 'https://ror.org/00bvhmc43', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210089594']}, {'id': 'https://openalex.org/I4210111366', 'display_name': 'Centre for Biomedical Network Research on Rare Diseases', 'ror': 'https://ror.org/01ygm5w19', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210111366']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'Javier Benítez', 'raw_affiliation_strings': ['Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'Spanish Network on Rare Diseases (CIBERER), Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}, {'raw_affiliation_string': 'Spanish Network on Rare Diseases (CIBERER), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210111366']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5039984802', 'display_name': 'Ana Osório', 'orcid': 'https://orcid.org/0000-0001-8124-3984'}, 'institutions': [{'id': 'https://openalex.org/I4210089594', 'display_name': 'Spanish National Cancer Research Centre', 'ror': 'https://ror.org/00bvhmc43', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210089594']}, {'id': 'https://openalex.org/I4210111366', 'display_name': 'Centre for Biomedical Network Research on Rare Diseases', 'ror': 'https://ror.org/01ygm5w19', 'country_code': 'ES', 'type': 'facility', 'lineage': ['https://openalex.org/I4210111366']}], 'countries': ['ES'], 'is_corresponding': True, 'raw_author_name': 'Ana Osorio', 'raw_affiliation_strings': ['Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'Spanish Network on Rare Diseases (CIBERER), Madrid, Spain'], 'affiliations': [{'raw_affiliation_string': 'Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}, {'raw_affiliation_string': 'Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210089594']}, {'raw_affiliation_string': 'Spanish Network on Rare Diseases (CIBERER), Madrid, Spain', 'institution_ids': ['https://openalex.org/I4210111366']}]}], 'countries_distinct_count': 3, 'institutions_distinct_count': 6, 'corresponding_author_ids': ['https://openalex.org/A5039984802'], 'corresponding_institution_ids': ['https://openalex.org/I4210089594', 'https://openalex.org/I4210111366'], 'apc_list': {'value': 2950, 'currency': 'USD', 'value_usd': 2950, 'provenance': 'doaj'}, 'apc_paid': {'value': 2950, 'currency': 'USD', 'value_usd': 2950, 'provenance': 'doaj'}, 'fwci': 0.873, 'has_fulltext': False, 'cited_by_count': 8, 'citation_normalized_percentile': {'value': 0.999962, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '12', 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10123', 'display_name': 'Molecular Mechanisms of DNA Damage Response', 'score': 0.9941, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10769', 'display_name': 'Genetic Research on BRCA Mutations and Cancer Risk', 'score': 0.9832, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/olaparib', 'display_name': 'Olaparib', 'score': 0.9685801}, {'id': 'https://openalex.org/keywords/synthetic-lethality', 'display_name': 'Synthetic lethality', 'score': 0.95215964}, {'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.86525583}, {'id': 'https://openalex.org/keywords/lethality', 'display_name': 'Lethality', 'score': 0.71730614}, {'id': 'https://openalex.org/keywords/parp-inhibitors', 'display_name': 'PARP Inhibitors', 'score': 0.550008}, {'id': 'https://openalex.org/keywords/brca1', 'display_name': 'BRCA1', 'score': 0.519993}, {'id': 'https://openalex.org/keywords/brca1/2-deficiency', 'display_name': 'BRCA1/2 Deficiency', 'score': 0.504109}, {'id': 'https://openalex.org/keywords/parp1', 'display_name': 'PARP1', 'score': 0.4398949}], 'concepts': [{'id': 'https://openalex.org/C2779962180', 'wikidata': 'https://www.wikidata.org/wiki/Q7083106', 'display_name': 'Olaparib', 'level': 5, 'score': 0.9685801}, {'id': 'https://openalex.org/C2778502085', 'wikidata': 'https://www.wikidata.org/wiki/Q7662767', 'display_name': 'Synthetic lethality', 'level': 4, 'score': 0.95215964}, {'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.86525583}, {'id': 'https://openalex.org/C20379349', 'wikidata': 'https://www.wikidata.org/wiki/Q1720706', 'display_name': 'Lethality', 'level': 2, 'score': 0.71730614}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.67578065}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6156542}, {'id': 'https://openalex.org/C2778480876', 'wikidata': 'https://www.wikidata.org/wiki/Q21112674', 'display_name': 'PARP1', 'level': 5, 'score': 0.4398949}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3918547}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.3397718}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.2663053}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.22674552}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.15756577}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.13749865}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.123779684}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.09944022}], 'mesh': [], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.3389/fonc.2022.888810', 'pdf_url': 'https://www.frontiersin.org/articles/10.3389/fonc.2022.888810/pdf', 'source': {'id': 'https://openalex.org/S2596394214', 'display_name': 'Frontiers in Oncology', 'issn_l': '2234-943X', 'issn': ['2234-943X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320527', 'host_organization_name': 'Frontiers Media', 'host_organization_lineage': ['https://openalex.org/P4310320527'], 'host_organization_lineage_names': ['Frontiers Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127384', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://eprints.whiterose.ac.uk/187503/1/fonc-12-888810.pdf', 'pdf_url': 'https://eprints.whiterose.ac.uk/187503/1/fonc-12-888810.pdf', 'source': {'id': 'https://openalex.org/S4306400854', 'display_name': 'White Rose Research Online (University of Leeds, The University of Sheffield, University of York)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I2800616092', 'host_organization_name': 'White Rose University Consortium', 'host_organization_lineage': ['https://openalex.org/I2800616092'], 'host_organization_lineage_names': ['White Rose University Consortium'], 'type': 'repository'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'acceptedVersion', 'is_accepted': True, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/35619904', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.3389/fonc.2022.888810', 'pdf_url': 'https://www.frontiersin.org/articles/10.3389/fonc.2022.888810/pdf', 'source': {'id': 'https://openalex.org/S2596394214', 'display_name': 'Frontiers in Oncology', 'issn_l': '2234-943X', 'issn': ['2234-943X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320527', 'host_organization_name': 'Frontiers Media', 'host_organization_lineage': ['https://openalex.org/P4310320527'], 'host_organization_lineage_names': ['Frontiers Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.86, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 44, 'referenced_works': ['https://openalex.org/W1564224574', 'https://openalex.org/W1578932543', 'https://openalex.org/W1964875336', 'https://openalex.org/W1973268287', 'https://openalex.org/W1982778042', 'https://openalex.org/W1984301575', 'https://openalex.org/W1985357654', 'https://openalex.org/W1990963919', 'https://openalex.org/W1998129814', 'https://openalex.org/W2009007206', 'https://openalex.org/W2062067118', 'https://openalex.org/W2065107886', 'https://openalex.org/W2096027508', 'https://openalex.org/W2118211359', 'https://openalex.org/W2121186077', 'https://openalex.org/W2131786456', 'https://openalex.org/W2154111088', 'https://openalex.org/W2154828075', 'https://openalex.org/W2166191449', 'https://openalex.org/W2369486488', 'https://openalex.org/W2548423821', 'https://openalex.org/W2597062310', 'https://openalex.org/W2613926645', 'https://openalex.org/W2627871710', 'https://openalex.org/W2704159227', 'https://openalex.org/W2728169914', 'https://openalex.org/W2732346161', 'https://openalex.org/W2755580525', 'https://openalex.org/W2888002479', 'https://openalex.org/W2888600000', 'https://openalex.org/W2901500625', 'https://openalex.org/W2902159788', 'https://openalex.org/W2914604310', 'https://openalex.org/W2951058429', 'https://openalex.org/W2964287298', 'https://openalex.org/W2968820602', 'https://openalex.org/W2980322460', 'https://openalex.org/W3006045662', 'https://openalex.org/W3022184968', 'https://openalex.org/W3098294146', 'https://openalex.org/W3137288611', 'https://openalex.org/W3158465240', 'https://openalex.org/W3217595020', 'https://openalex.org/W4200382597'], 'related_works': ['https://openalex.org/W4362541711', 'https://openalex.org/W4361821986', 'https://openalex.org/W4296617455', 'https://openalex.org/W4229451438', 'https://openalex.org/W3216411852', 'https://openalex.org/W3135348276', 'https://openalex.org/W3107459115', 'https://openalex.org/W2807317098', 'https://openalex.org/W2515153059', 'https://openalex.org/W1986471561'], 'abstract_inverted_index': {'PARP1': [0, 13], 'plays': [1], 'a': [2, 21, 94, 159, 172], 'critical': [3], 'role': [4], 'in': [5, 25, 57, 116, 140, 165], 'the': [6, 26, 44, 90, 110, 125, 132, 135, 141, 152, 176], 'base': [7], 'excision': [8], 'repair': [9], '(BER)': [10], 'pathway,': [11], 'and': [12, 52, 60, 101, 109, 168, 181], 'inhibition': [14, 157], 'leads': [15], 'to': [16, 34, 48, 64, 88, 124, 134, 171], 'specific': [17], 'cell': [18, 120], 'death,': [19], 'through': [20], 'synthetic': [22, 76, 162], 'lethal': [23, 77], 'interaction,': [24], 'context': [27, 142], 'of': [28, 46, 143, 178], 'BRCA1/2': [29], 'deficiency.': [30], 'To': [31, 83], 'date,': [32], 'up': [33], 'five': [35], 'different': [36], 'PARP': [37, 136], 'inhibitors': [38], '(PARPi),': [39], 'have': [40], 'been': [41], 'approved,': [42], 'nevertheless,': [43], 'acquisition': [45], 'resistance': [47], 'PARPi': [49, 107], 'is': [50, 54, 158], 'common': [51], 'there': [53], 'increasing': [55], 'interest': [56], 'enhancing': [58], 'responses': [59], 'expand': [61], 'their': [62], 'use': [63], 'other': [65, 70], 'tumour': [66], 'types.We': [67], 'hypothesized': [68], 'that': [69, 155], 'BER': [71], 'members': [72], 'could': [73, 169], 'be': [74], 'additional': [75], 'partners': [78], 'with': [79, 106], 'mutated': [80], 'BRCA': [81], 'genes.': [82], 'test': [84], 'this,': [85], 'we': [86], 'decided': [87], 'evaluate': [89], 'glycosylase': [91], 'OGG1': [92, 111, 126, 156], 'as': [93], 'potential': [95], 'candidate,': [96], 'by': [97], 'treating': [98], 'BRCA1': [99, 115, 144], 'proficient': [100], 'deficient': [102], 'breast': [103, 118, 180], 'cancer': [104, 119], 'cells': [105], 'olaparib': [108], 'inhibitor': [112, 127, 137], 'TH5478.Knocking': [113], 'out': [114], 'triple-negative': [117], 'lines': [121], 'causes': [122], 'hypersensitivity': [123], 'TH5487.': [128], 'Besides,': [129], 'TH5487': [130], 'enhances': [131], 'sensitivity': [133], 'olaparib,': [138], 'especially': [139], 'deficiency,': [145], 'reflecting': [146], 'an': [147], 'additive': [148], 'interaction.These': [149], 'results': [150], 'provide': [151], 'first': [153], 'evidence': [154], 'promising': [160], 'new': [161, 173], 'lethality': [163], 'strategy': [164], 'BRCA1-deficient': [166], 'cells,': [167], 'lead': [170], 'framework': [174], 'for': [175], 'treatment': [177], 'hereditary': [179], 'ovarian': [182], 'cancer.': [183]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4229451438', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 1}], 'updated_date': '2024-09-12T08:47:32.489764', 'created_date': '2022-05-11'}